Latest Competition News

Sparc Hydrogen has appointed Alana Barlow as its inaugural CEO, marking a strategic move to accelerate commercialisation of its innovative photocatalytic water splitting technology for green hydrogen.

Cluey Ltd has formalised its acquisition of Education Futures Group, the parent of Art of Smart, in a deal valued up to $6.5 million combining cash and shares. Completion is expected by January 2026, contingent on conditions and an ongoing entitlement offer.

Chalice Mining’s Pre-Feasibility Study confirms the Gonneville Project as a globally significant palladium-nickel-copper mine in Western Australia, boasting robust returns and a rapid payback period.

Telix Pharmaceuticals has dosed the first patient in the randomized expansion phase of its pivotal ProstACT Global Phase 3 trial for TLX591, targeting advanced prostate cancer. The trial is expanding globally, with regulatory submissions underway in the US and Europe.

Chalice Mining’s Pre-Feasibility Study confirms the Gonneville Project as a long-life, low-cost critical minerals mine in Western Australia, projecting A$4.7 billion pre-tax free cashflow over 23 years with rapid payback.

Australian Vintage Limited has secured a five-year distribution agreement to represent Invivo's wine portfolio in the UK and Ireland, promising significant revenue and volume growth.

Prominence Energy has secured the last regulatory approval needed to complete its acquisition of the Gawler Hydrogen Project, setting the stage for exploration of natural hydrogen in South Australia.

Ardea Resources updates its Definitive Feasibility Study for the Kalgoorlie Nickel Project, confirming a streamlined processing approach and a new sale product that could enhance project economics and market reach.

Antares Metals Limited has voluntarily suspended trading of its shares pending a significant announcement about a proposed acquisition and capital raising, expected by 8 December 2025.

Swoop Holdings has successfully closed the institutional segment of its entitlement offer, securing $2.8 million at $0.10 per share, with the retail component set to launch on December 10.

Island Pharmaceuticals has been granted a pivotal US patent extending protection for its antiviral drug Galidesivir as a Covid-19 treatment until 2042, reinforcing its strategic position in the antiviral market.

Panther Metals has successfully closed a $502,000 entitlement offer, backed strongly by major shareholders and directors, to fund key exploration projects in Western Australia and the Northern Territory.